10x Genomics wins patent verdict against Parse with over $4.8 million damages

Verifying
  • 10x Genomics won a jury finding that Parse willfully infringed three Scale-licensed patents.
  • $4.8 million-plus in damages covered Parse Evercode sales from February 2021 through June 30, 2026.
  • The jury found all three patents valid and enforceable, according to 10x Genomics.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.